| Prevascar in African Continental Group Scarring (NCT01115868) | Renovo | 2010-04-01 |
| Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector (NCT01129544) | David Williams | 2010-04-01 |
| TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients (NCT01202825) | Tibotec Pharmaceuticals, Ireland | 2010-04-01 |
| Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects (NCT01095588) | VIVUS LLC | 2010-04-01 |
| Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer (NCT01155791) | Sandy Srinivas | 2010-04-01 |
| An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects (NCT01105234) | LEO Pharma | 2010-04-01 |
| A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring (NCT01144676) | International Partnership for Microbicides, Inc. | 2010-04-01 |
| A Trial Investigating NN1218 in Subjects With Type 1 Diabetes (NCT01121289) | Novo Nordisk A/S | 2010-04-01 |
| Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy (NCT01153100) | University of Colorado, Denver | 2010-04-01 |
| Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment (NCT01120314) | Sanofi | 2010-04-01 |
| Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma (NCT01074060) | City of Hope Medical Center | 2010-04-01 |
| Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) (NCT01111851) | Merck Sharp & Dohme LLC | 2010-04-01 |
| Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality in Healthy Male Subjects (NCT01095601) | VIVUS LLC | 2010-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia (NCT01114126) | Neurim Pharmaceuticals Ltd. | 2010-04-01 |
| E-health Intervention for Cancer Survivors (NCT01114802) | Northwestern University | 2010-04-01 |
| Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients (NCT01118754) | Santen Inc. | 2010-04-01 |
| A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects (NCT01109680) | Merz Pharmaceuticals GmbH | 2010-04-01 |
| Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease (NCT01085201) | Dana-Farber Cancer Institute | 2010-04-01 |
| A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1 (NCT01181024) | Hoffmann-La Roche | 2010-04-01 |
| Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects (NCT01415128) | VIVUS LLC | 2010-04-01 |
| Reversing Type 1 Diabetes After it is Established (NCT01106157) | University of Florida | 2010-04-01 |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects (NCT02029482) | Actelion | 2010-04-01 |
| Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers (NCT01162486) | Johns Hopkins University | 2010-04-01 |
| Task Specific Exercise for the Prevention of Disability (NCT01183507) | University of Florida | 2010-04-01 |
| Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery (NCT00990795) | The University of Texas Health Science Center, Houston | 2010-04-01 |
| GOS Prebiotic Effect in Children Constipation (NCT02183766) | University of Campinas, Brazil | 2010-04-01 |
| Pharmacokinetic Study to Compare Two Formulations of Paracetamol (NCT01767428) | GlaxoSmithKline | 2010-04-01 |
| Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00864110) | Cell>Point LLC | 2010-04-01 |
| A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007 (NCT01061788) | Jeffrey Clarke | 2010-04-01 |
| Effects of Lutein Supplementation on Oxidative Stress and Inflammation in Healthy Nonsmokers (NCT01056094) | Peking University | 2010-04-01 |
| GSK1349572 Relative Bioavailability Study (NCT01098513) | ViiV Healthcare | 2010-04-01 |
| Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours (NCT01135563) | The Hospital for Sick Children | 2010-04-01 |
| Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin (NCT01146483) | Centre hospitalier de l'Université de Montréal (CHUM) | 2010-04-01 |
| Evaluating Central Line Hub Contamination Using a Novel Capping Device (NCT01301300) | Endeavor Health | 2010-04-01 |
| Adenosine Cardioplegia; Improved Cardioprotection? (NCT01123525) | University Hospital of North Norway | 2010-04-01 |
| Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers (NCT01101152) | University of Ottawa | 2010-04-01 |
| ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies (NCT01110473) | AbbVie (prior sponsor, Abbott) | 2010-04-01 |
| Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers (NCT01116011) | AstraZeneca | 2010-04-01 |
| Safety Study of BMS-844421 for Treatment of Hypercholesterolemia (NCT01082562) | Bristol-Myers Squibb | 2010-04-01 |
| Mindfulness-Based Cognitive Therapy for the Treatment of Chronic Headache Pain (NCT01213056) | University of Alabama, Tuscaloosa | 2010-04-01 |
| Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors (NCT01129349) | Amgen | 2010-04-01 |
| Deep Brain Stimulation Effects Study (NCT01098565) | MedtronicNeuro | 2010-04-01 |
| Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine (NCT01084291) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-01 |
| Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa (NCT01113281) | Serum Life Science Europe GmbH | 2010-04-01 |
| Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma (NCT01168752) | Debiopharm International SA | 2010-04-01 |
| A Study to Compare Two Paracetamol Tablets (NCT01381640) | GlaxoSmithKline | 2010-04-01 |
| Azacitidine and Lenalidomide for Acute Myeloid Leukemia (NCT01016600) | Washington University School of Medicine | 2010-04-01 |
| A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT01106599) | Genentech, Inc. | 2010-04-01 |
| Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C (NCT01037621) | G.V. (Sonny) Montgomery VA Medical Center | 2010-04-01 |
| Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis (NCT01113333) | Sanofi | 2010-04-01 |
| Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors (NCT01111097) | University of Florida | 2010-04-01 |
| A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers (NCT01115322) | Stiefel, a GSK Company | 2010-04-01 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors (NCT01065623) | Bayer | 2010-04-01 |
| Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers (NCT01092845) | Pfizer | 2010-04-01 |
| AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA) (NCT00981006) | Naofumi Takehara | 2010-04-01 |
| A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers (NCT01114841) | Stiefel, a GSK Company | 2010-03-31 |
| A First in Man Study of MABp1 in Patients With Advanced Cancers (NCT01021072) | Janssen Research & Development, LLC | 2010-03-31 |
| Physical, Functional and Neural Effects of Two Lower Extremity Exercise Protocols in Children With Cerebral Palsy (NCT01086670) | National Institutes of Health Clinical Center (CC) | 2010-03-30 |
| Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862 (NCT01473108) | Bayer | 2010-03-29 |
| Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT01060384) | University of Nebraska | 2010-03-29 |
| Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas (NCT01078649) | Debiopharm International SA | 2010-03-29 |
| Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors (NCT01127178) | Eisai Inc. | 2010-03-29 |
| Bioequivalence Trial of Alprazolam 2 mg Tablets (NCT01745575) | GlaxoSmithKline | 2010-03-28 |
| A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers (NCT01112787) | Stiefel, a GSK Company | 2010-03-26 |
| Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT01088048) | Gilead Sciences | 2010-03-25 |
| Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients (NCT03945526) | Indonesia University | 2010-03-23 |
| Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine (NCT01092611) | GlaxoSmithKline | 2010-03-22 |
| An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study (NCT01090414) | Gilead Sciences | 2010-03-22 |
| CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy (NCT01029366) | University of Pennsylvania | 2010-03-17 |
| GSK1349572 Drug Interaction Study With Efavirenz (NCT01098526) | ViiV Healthcare | 2010-03-16 |
| Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma (NCT01064648) | National Cancer Institute (NCI) | 2010-03-15 |
| An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . (NCT01077505) | GlaxoSmithKline | 2010-03-15 |
| Study to Evaluate the Safety of Rotarix™ in Chinese Children (NCT01086436) | GlaxoSmithKline | 2010-03-13 |
| A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects (NCT01087645) | Novo Nordisk A/S | 2010-03-12 |
| Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004) (NCT01088711) | Merck Sharp & Dohme LLC | 2010-03-11 |
| A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers (NCT01072214) | GlaxoSmithKline | 2010-03-09 |
| FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT01133990) | Eisai Inc. | 2010-03-04 |
| Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer (NCT01093183) | University of Nebraska | 2010-03-04 |
| Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults (NCT01086449) | GlaxoSmithKline | 2010-03-04 |
| Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects (NCT01128634) | GlaxoSmithKline | 2010-03-04 |
| A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies (NCT01100944) | National Cancer Institute (NCI) | 2010-03-04 |
| A Study Of PF-04449913 In Select Hematologic Malignancies (NCT00953758) | Pfizer | 2010-03-03 |
| Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension (NCT01105208) | Bayer | 2010-03-01 |
| Single-dose Safety Study of APD916 in Healthy Volunteers (NCT01093508) | Arena Pharmaceuticals | 2010-03-01 |
| Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma (NCT01057615) | Indiana University | 2010-03-01 |
| A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis (NCT01097590) | IBD Column Therapies International AB | 2010-03-01 |
| Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (NCT01613573) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2010-03-01 |
| A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin (NCT01953887) | Astellas Pharma Europe B.V. | 2010-03-01 |
| Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer (NCT01207895) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| Pilot Study of Mindfulness-Based Stress Reduction for Patients With Persistent Cancer-Related Fatigue (NCT01247532) | Indiana University | 2010-03-01 |
| Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers (NCT01101932) | Pfizer | 2010-03-01 |
| N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma (NCT01019850) | New Approaches to Neuroblastoma Therapy Consortium | 2010-03-01 |
| Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine (NCT01024686) | Seattle Children's Hospital | 2010-03-01 |
| The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 (NCT01071720) | Chong Kun Dang Pharmaceutical | 2010-03-01 |
| A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women (NCT01143194) | dsm-firmenich Switzerland AG | 2010-03-01 |
| Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor (NCT01123876) | AbbVie (prior sponsor, Abbott) | 2010-03-01 |
| To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications (NCT01103739) | Pfizer | 2010-03-01 |
| Point-of-Choice Prompts to Reduce Prolonged Sitting Time at Work (NCT01628861) | Glasgow Caledonian University | 2010-03-01 |
| Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function (NCT00997399) | Novartis Pharmaceuticals | 2010-03-01 |
| Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases (NCT01191632) | Heidelberg University | 2010-03-01 |